EyePoint Pharmaceuticals Inc (EYPT)
19.74
-0.20
(-1.00%)
USD |
NASDAQ |
May 03, 16:00
19.73
-0.01
(-0.05%)
After-Hours: 20:00
EyePoint Pharmaceuticals Free Cash Flow (Quarterly): -23.99M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -23.99M |
| September 30, 2023 | -16.92M |
| June 30, 2023 | 56.63M |
| March 31, 2023 | -17.32M |
| December 31, 2022 | -13.17M |
| September 30, 2022 | -14.33M |
| June 30, 2022 | -19.34M |
| March 31, 2022 | -20.31M |
| December 31, 2021 | -16.67M |
| September 30, 2021 | -7.918M |
| June 30, 2021 | -10.57M |
| March 31, 2021 | -15.10M |
| December 31, 2020 | 5.703M |
| September 30, 2020 | 1.008M |
| June 30, 2020 | -5.147M |
| March 31, 2020 | -16.36M |
| December 31, 2019 | -11.49M |
| September 30, 2019 | -14.77M |
| June 30, 2019 | -17.13M |
| March 31, 2019 | -13.52M |
| September 30, 2018 | -11.88M |
| June 30, 2018 | -6.126M |
| March 31, 2018 | -4.819M |
| December 31, 2017 | -5.038M |
| September 30, 2017 | -6.032M |
| Date | Value |
|---|---|
| June 30, 2017 | -4.578M |
| March 31, 2017 | -4.559M |
| December 31, 2016 | -5.014M |
| September 30, 2016 | -6.486M |
| June 30, 2016 | -4.393M |
| March 31, 2016 | -4.333M |
| December 31, 2015 | -3.199M |
| September 30, 2015 | -4.504M |
| June 30, 2015 | -3.096M |
| March 31, 2015 | -3.997M |
| December 31, 2014 | 21.23M |
| September 30, 2014 | -4.00M |
| June 30, 2014 | -2.958M |
| March 31, 2014 | -1.906M |
| December 31, 2013 | -2.27M |
| September 30, 2013 | -3.785M |
| June 30, 2013 | -3.399M |
| March 31, 2013 | -1.975M |
| December 31, 2012 | -1.814M |
| September 30, 2012 | -1.625M |
| June 30, 2012 | -1.844M |
| March 31, 2012 | -2.162M |
| December 31, 2011 | -2.519M |
| September 30, 2011 | -2.881M |
| June 30, 2011 | 1.18M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-23.99M
Minimum
Dec 2023
56.63M
Maximum
Jun 2023
-9.327M
Average
-14.77M
Median
Sep 2019
Free Cash Flow (Quarterly) Benchmarks
| INVO Bioscience Inc | -0.7899M |
| Bio-Path Holdings Inc | -1.814M |
| Ocular Therapeutix Inc | -22.91M |
| Aileron Therapeutics Inc | -10.39M |
| Apellis Pharmaceuticals Inc | -97.97M |